ABEO Schedule 13G: 3.01M Shares, 5.3% Stake
Abeona Therapeutics ownership disclosure: Funicular Funds, LP, Cable Car Capital, LP and Jacob Ma-Weaver each report beneficial ownership of 3,007,329 shares of Abeona Therapeutics common stock, representing 5.3% of the class.
Rhea-AI Filing Summary
Abeona Therapeutics ownership disclosure: Funicular Funds, LP, Cable Car Capital, LP and Jacob Ma-Weaver each report beneficial ownership of 3,007,329 shares of Abeona Therapeutics common stock, representing 5.3% of the class. The calculation references 57,049,023 shares outstanding as of March 17, 2026. The filings list sole voting and sole dispositive power over the reported shares and provide the filers' business address in San Francisco.
Positive
- None.
Negative
- None.
Insights
Large passive stake disclosed by related entities and individual.
The filing shows a 3,007,329-share position controlled by Funicular Funds, Cable Car Capital (its general partner), and Jacob Ma-Weaver as managing member, each reported at 5.3% of outstanding shares based on the issuer's March 17, 2026 count of 57,049,023.
This is a straightforward beneficial ownership disclosure; subsequent filing activity would determine whether this stake is passive or part of an active engagement. Future SEC filings may show changes in holdings or intentions.
Key Figures
Key Terms
Beneficial ownership regulatory
Sole dispositive power regulatory
Schedule 13G regulatory
General Partner other
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Funicular Funds report in Abeona Therapeutics (ABEO)?
Who else is listed with the same ownership amount in the ABEO filing?
Where is the filer’s address and who signed the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.